Alpha 2.0
Login Register
» Authors » Andrea Perrottelli

Andrea Perrottelli

Explore the profile of Andrea Perrottelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 143
Followers 0
Related Specialties
Psychiatry
General Medicine
Neurology
Top 10 Co-Authors
Silvana Galderisi
Luigi Giuliani
Armida Mucci
Pasquale Pezzella
Giulia Maria Giordano
Mario Maj
Paola Bucci
Giulia M Giordano
Giorgio Di Lorenzo
Edoardo Caporusso
Published In
J Clin Med
Front Psychiatry
Brain Sci
Eur Neuropsychopharmacol
Eur Psychiatry
Affiliations
Soon will be listed here.
Recent Articles
1.
Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale
Wolpe N, Perrottelli A, Giuliani L, Yang Z, Rekhi G, Jones P, et al.
Eur Neuropsychopharmacol . 2025 Feb; 93:68-76. PMID: 40020376
The negative symptoms of schizophrenia can determine functional outcome in patients. Despite its clinical significance, no treatment exists to date, as numerous pharmacological and non-pharmacological clinical trials have failed to...
2.
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review
Melillo A, Perrottelli A, Caporusso E, Coltorti A, Giordano G, Giuliani L, et al.
Eur Psychiatry . 2024 Sep; 67(1):e60. PMID: 39328154
Background: Cognitive impairment (CI) is one of the most prevalent and burdensome consequences of COVID-19 infection, which can persist up to months or even years after remission of the infection....
3.
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia
Giuliani L, Pezzella P, Giordano G, Fazio L, Mucci A, Perrottelli A, et al.
Front Psychiatry . 2024 Aug; 15:1458624. PMID: 39165501
Background: The development of neuroimaging biomarkers in patients with schizophrenia (SCZ) requires a refined clinical characterization. A limitation of the neuroimaging literature is the partial uptake of progress in characterizing...
4.
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
Perrottelli A, Marzocchi F, Caporusso E, Giordano G, Giuliani L, Melillo A, et al.
J Psychiatry Neurosci . 2024 Mar; 49(2):E109-E125. PMID: 38490647
The pathophysiology of schizophrenia and bipolar disorder involves a complex interaction between genetic and environmental factors that begins in the early stages of neurodevelopment. Recent advancements in the field of...
5.
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices
Galderisi S, Perrottelli A, Giuliani L, Pisaturo M, Monteleone P, Pagliano P, et al.
Eur Neuropsychopharmacol . 2023 Dec; 79:22-31. PMID: 38065006
Cognitive impairment (CI) is regarded as a remarkable burden in COVID-19 survivors. Its prevalence and profile, and relationships with the disease clinical and laboratory indices, remain unclear. The present study...
6.
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review
Melillo A, Caporusso E, Giordano G, Giuliani L, Pezzella P, Perrottelli A, et al.
J Clin Med . 2023 Nov; 12(22). PMID: 38002707
The present review aims to identify correlations between negative symptoms (NS) and deficits in neurocognition and social cognition in subjects with first-episode psychosis (FEP) and at-high-risk populations (HR). A systematic...
7.
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia
Rucci P, Caporusso E, Sanmarchi F, Giordano G, Mucci A, Giuliani L, et al.
BJPsych Open . 2023 Sep; 9(5):e168. PMID: 37674282
Background: The structure of negative symptoms of schizophrenia is still a matter of controversy. Although a two-dimensional model (comprising the expressive deficit dimension and the motivation and pleasure dimension) has...
8.
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome
Giuliani L, Koutsouleris N, Giordano G, Koenig T, Mucci A, Perrottelli A, et al.
Eur Psychiatry . 2023 May; 66(1):e46. PMID: 37231770
Background: Different electrophysiological (EEG) indices have been investigated as possible biomarkers of schizophrenia. However, these indices have a very limited use in clinical practice, as their associations with clinical and...
9.
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study
Giordano G, Pezzella P, Giuliani L, Fazio L, Mucci A, Perrottelli A, et al.
Brain Sci . 2023 Jan; 13(1). PMID: 36672064
The aim of the present study was to examine the neurobiological correlates of the two negative symptom domains of schizophrenia, the Motivational Deficit domain (including avolition, anhedonia, and asociality) and...
10.
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature
Perrottelli A, Sansone N, Giordano G, Caporusso E, Giuliani L, Melillo A, et al.
J Pers Med . 2022 Dec; 12(12). PMID: 36556290
The present study aims to provide a critical overview of the literature on the relationships between post-acute COVID-19 infection and cognitive impairment, highlighting the limitations and confounding factors. A systematic...